sodium methylate
tenatoprazole
Conditions | Yield |
---|---|
In methanol at -5℃; for 18h; | 79.4% |
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine
tenatoprazole
Conditions | Yield |
---|---|
With 3-chloro-benzenecarboperoxoic acid In chloroform at -15 - -10℃; Large scale reaction; | 74% |
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 1h; | 66.4% |
With 3-chloro-benzenecarboperoxoic acid In chloroform |
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine
B
tenatoprazole
Conditions | Yield |
---|---|
With 3-chloro-benzenecarboperoxoic acid In chloroform at 5℃; for 0.0166667h; Product distribution / selectivity; |
tenatoprazole
methyl iodide
5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-ylmethanesulfinyl)-1-methyl-1H-imidazo[4,5-b]pyridine
Conditions | Yield |
---|---|
With dmap; potassium carbonate In dichloromethane at 25 - 30℃; for 10h; | 91.3% |
tenatoprazole
A
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine
Conditions | Yield |
---|---|
With D-glucose-6-; nicotinamide adenine dinucleotide phosphate; yeast glucose-6-phosphate dehydrogenase In aq. phosphate buffer at 37℃; pH=7.4; Catalytic behavior; Kinetics; Reagent/catalyst; Enzymatic reaction; regioselective reaction; | A n/a B 8.2% C 1.3% |
With G1T mutant of CYP102A1; NADPH In aq. phosphate buffer; dimethyl sulfoxide at 37℃; for 2h; pH=7.4; Reagent/catalyst; Time; Enzymatic reaction; |
(4-chlorosulfonylphenoxy)acetic acid 2-(toluene-4-sulfonyl)ethyl ester
tenatoprazole
A
2-tosylethyl 2-{4-[5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-imidazo[4,5-b]pyridine-1-ylsulfonyl]-phenoxy}-acetate
B
2-tosylethyl 2-{4-[5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-3H-imidazo[4,5-b]pyridine-3-ylsulfonyl]-phenoxy}-acetate
Conditions | Yield |
---|---|
With sodium hydrogencarbonate; triethylamine In dichloromethane at 20℃; |
tenatoprazole
Conditions | Yield |
---|---|
Resolution of racemate; | |
Resolution of racemate; |
2-[(chlorocarbonyl)(methyl)amino]ethyl ethyl carbonate
tenatoprazole
Conditions | Yield |
---|---|
With triethylamine; dmap In tetrahydrofuran at 60℃; for 6h; | |
With dmap; triethylamine In tetrahydrofuran at 60℃; for 6h; | 0.721 g |
2-[(chlorocarbonyl) (phenyl)amino]ethyl acetate
tenatoprazole
Conditions | Yield |
---|---|
With triethylamine; dmap In tetrahydrofuran at 60℃; for 10h; | |
With dmap; triethylamine In tetrahydrofuran at 60℃; for 10h; | 0.311 g |
tenatoprazole
Conditions | Yield |
---|---|
Resolution of racemate; |
tenatoprazole
Conditions | Yield |
---|---|
With triethylamine; dmap In tetrahydrofuran at 60℃; for 5h; | |
With dmap; triethylamine In tetrahydrofuran at 60℃; for 5h; | 0.173 g |
tenatoprazole
Conditions | Yield |
---|---|
With triethylamine; dmap In tetrahydrofuran at 60℃; for 14h; | |
With dmap; triethylamine In tetrahydrofuran at 60℃; for 14h; | 0.360 g |
bis(trichloromethyl) carbonate
1-acetoxy-2-methylaminoethane hydrochloride
tenatoprazole
Conditions | Yield |
---|---|
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h; Stage #2: 1-acetoxy-2-methylaminoethane hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 2h; Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 5h; |
2-(methylamino)ethyl 3-chlorobenzoate hydrochloride
bis(trichloromethyl) carbonate
tenatoprazole
Conditions | Yield |
---|---|
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h; Stage #2: 2-(methylamino)ethyl 3-chlorobenzoate hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 2.5h; Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 14h; |
ethyl 2-(methylamino)ethyl carbonate hydrochloride
bis(trichloromethyl) carbonate
tenatoprazole
Conditions | Yield |
---|---|
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h; Stage #2: ethyl 2-(methylamino)ethyl carbonate hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 2.5h; Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 6h; |
2-anilinoethyl acetate hydrochloride
bis(trichloromethyl) carbonate
tenatoprazole
Conditions | Yield |
---|---|
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h; Stage #2: 2-anilinoethyl acetate hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 3h; Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 10h; |
tenatoprazole
Conditions | Yield |
---|---|
With potassium hydroxide In water at 0℃; for 12h; Product distribution / selectivity; |
Conditions | Yield |
---|---|
With G1T mutant of CYP102A1 for 0.5h; Kinetics; Reagent/catalyst; Enzymatic reaction; |
Molecule structure of Tenatoprazole (CAS NO.113712-98-4):
IUPAC Name: 5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine
Molecular Weight: 346.40412 g/mol
Molecular Formula: C16H18N4O3S
Density: 1.41 g/cm3
Boiling Point: 591.5 °C at 760 mmHg
Flash Point: 311.5 °C
Index of Refraction: 1.673
Molar Refractivity: 91.81 cm3
Molar Volume: 244.7 cm3
Surface Tension: 82.3 dyne/cm
Enthalpy of Vaporization: 88.22 kJ/mol
Vapour Pressure: 5.8E-14 mmHg at 25 °C
Storage Temp.: −20 °C
XLogP3-AA: 1.8
H-Bond Donor: 1
H-Bond Acceptor: 6
Rotatable Bond Count: 5
Tautomer Count: 3
Exact Mass: 346.109961
MonoIsotopic Mass: 346.109961
Topological Polar Surface Area: 90
Heavy Atom Count: 24
Canonical SMILES: CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=CC(=N3)OC
InChI: InChI=1S/C16H18N4O3S/c1-9-7-17-12(10(2)14(9)23-4)8-24(21)16-18-11-5-6-13(22-3)19-15(11)20-16/h5-7H,8H2,1-4H3,(H,18,19,20)
InChIKey: ZBFDAUIVDSSISP-UHFFFAOYSA-N
Product Categories: Heterocyclic Compounds; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds; API's
Tenatoprazole (CAS NO.113712-98-4) is used as a proton pump inhibitor for reduction and/or prevention of gastrointestinal disorders.
Hazard Codes: Xn
Risk Statements: 22-36/37/38
R22:Harmful if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36/37
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37:Wear suitable protective clothing and gloves.
Tenatoprazole (CAS NO.113712-98-4) is also named as (+-)-5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine ; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine ; Protop ; Tu 199 ; UNII-RE0689TX2K ; Ulsacare ; 1H-Imidazo(4,5-b)pyridine, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)- . Tenatoprazole (CAS NO.113712-98-4) is white crystalline powder. It is an imidazopyridine derivative and has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View